Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
| Published in: | Journal of Alzheimer's Disease Vol. 100; no. 3; pp. 973 - 987 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Sage Publications Inc.
2024
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178834278&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 178834278 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13872877 FLR jtl: Journal of Alzheimer's Disease issn: 13872877 maglogo: N pubinfo: dt: 2024 vid: 100 iid: 3 pid: 20732 pub: Sage Publications Inc. place: Thousand Oaks, California artinfo: ui: 178834278 10.3233/JAD-230442 178834278 ppf: 973 ppct: 14 formats: tig: atl: Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects. aug: au: Leng, Fangda Hinz, Rainer Gentleman, Steve Dani, Melanie Brooks, David J. Edison, Paul affil: Department of Brain Sciences, Imperial College London, London, UK sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|